Apotheken
|
Doctor
|
Drugs
|
Hospital
|
Interactions
|
MiGeL
|
Registration owner
|
Services
Home
<
List for "R03AK" (34)
–
Sort according to Concentration, Size and Price
Price comparison
Price comparison and Component
Brand name
Component
Registration owner
Indication
Interaction
Unwanted Effect
Swissmedic-# (5-digit)
Pharmacode
Product
Package Size
EFP
CP
SB
DC
Composition
Registr. Holder
Category
Salmeterol and Fluticasone (R03AK06) 11 products
WHO-DDD
DrugBank.ca
IP
CI
Seretide 50
120 unidose(s)
33.32
52.65
10 %
Metered dose aerosol: 2 Active Agents
GlaxoSmithKline AG
B / SL
FB
G
IP
CI
Seretide 125
120 unidose(s)
48.40
69.05
10 %
Metered dose aerosol: 2 Active Agents
GlaxoSmithKline AG
B / SL
FB
G
IP
CI
Seretide 250
120 unidose(s)
71.88
94.60
10 %
Metered dose aerosol: 2 Active Agents
GlaxoSmithKline AG
B / SL
FB
G
IP
CI
Seretide Diskus 100
60 unidose(s)
32.15
51.40
10 %
Multidosen-Pulverinhalator: 2 Active Agents
GlaxoSmithKline AG
B / SL
FB
G
IP
CI
Seretide Diskus 250
60 unidose(s)
46.70
67.20
10 %
Multidosen-Pulverinhalator: 2 Active Agents
GlaxoSmithKline AG
B / SL
FB
G
IP
CI
Seretide Diskus 500
60 unidose(s)
69.36
91.85
10 %
Multidosen-Pulverinhalator: 2 Active Agents
GlaxoSmithKline AG
B / SL
FB
G
IP
CI
Seffalair Spiromax 55/14 mcg
60
25.72
44.40
10 %
Multidosenpulverinhalator: 2 Active Agents
Teva Pharma AG
B / SL
FB
G
IP
CI
Seffalair Spiromax 113/14 mcg
60
37.36
57.05
10 %
Multidosenpulverinhalator: 2 Active Agents
Teva Pharma AG
B / SL
FB
G
IP
CI
Seffalair Spiromax 232/14 mcg
60
55.49
76.75
10 %
Multidosenpulverinhalator: 2 Active Agents
Teva Pharma AG
B / SL
FB
G
IP
CI
Salmeterol/Fluticasonpropionat
Devatis 25 μg/125 μg
120
k.A.
Metered dose aerosol: 2 Active Agents
Devatis AG
B
FB
G
IP
CI
Salmeterol/Fluticasonpropionat
Devatis 25 μg/250 μg
120
k.A.
Metered dose aerosol: 2 Active Agents
Devatis AG
B
FB
G
Formoterol and Budesonide (R03AK07) 7 products
WHO-DDD
DrugBank.ca
IP
CI
Vannair 100/6
120 unidose(s)
42.16
62.25
10 %
Metered dose aerosol: 2 Active Agents
AstraZeneca AG
B / SL
FB
G
IP
CI
Vannair 200/6
120 unidose(s)
47.90
68.50
10 %
Metered dose aerosol: 2 Active Agents
AstraZeneca AG
B / SL
FB
G
IP
CI
Symbicort 100/6
Turbuhaler
60 unidose(s)
22.40
40.80
10 %
Inhalation Powder: 2 Active Agents
AstraZeneca AG
B / SL
FB
G
IP
CI
Symbicort 100/6
Turbuhaler
120 unidose(s)
39.38
59.25
10 %
Inhalation Powder: 2 Active Agents
AstraZeneca AG
B / SL
FB
G
IP
CI
Symbicort 200/6
Turbuhaler
60 unidose(s)
25.44
44.10
10 %
Inhalation Powder: 2 Active Agents
AstraZeneca AG
B / SL
FB
G
IP
CI
Symbicort 200/6
Turbuhaler
120 unidose(s)
44.74
65.05
10 %
Inhalation Powder: 2 Active Agents
AstraZeneca AG
B / SL
FB
G
IP
CI
Symbicort 400/12
Turbuhaler
60 unidose(s)
40.84
60.85
10 %
Inhalation Powder: 2 Active Agents
AstraZeneca AG
B / SL
FB
G
Formoterol and Beclometasone (R03AK08) 3 products
WHO-DDD
DrugBank.ca
IP
CI
Foster 100 μg / 6 μg
120
48.00
68.60
10 %
Solution pour inhalation en flacon pressurisé: 2 Active Agents
Chiesi SA
B / SL
FB
G
IP
CI
Foster 200 μg / 6 μg
120
49.01
69.70
10 %
solution pour inhalation en flacon pressurisé: 2 Active Agents
Chiesi SA
B / SL
FB
G
IP
CI
Foster 100 μg / 6 μg
240
k.A.
Solution pour inhalation en flacon pressurisé: 2 Active Agents
Chiesi SA
B
FB
G
Vilanterol and Fluticasone Furoate (R03AK10) 4 products
WHO-DDD
DrugBank.ca
IP
CI
PP
Relvar Ellipta 92/22 mcg
30 unidose(s)
26.01
44.70
10 %
Einzeldosiertes Pulver zur Inhalation: 2 Active Agents
GlaxoSmithKline AG
B / SL
FB
G
IP
CI
PP
Relvar Ellipta 92/22 mcg
3 x 30
78.02
101.25
10 %
Einzeldosiertes Pulver zur Inhalation: 2 Active Agents
GlaxoSmithKline AG
B / SL
FB
G
IP
CI
PP
Relvar Ellipta 184/22 mcg
30 unidose(s)
32.98
52.30
10 %
Einzeldosiertes Pulver zur Inhalation: 2 Active Agents
GlaxoSmithKline AG
B / SL
FB
G
IP
CI
PP
Relvar Ellipta 184/22 mcg
3 x 30
98.95
124.05
10 %
Einzeldosiertes Pulver zur Inhalation: 2 Active Agents
GlaxoSmithKline AG
B / SL
FB
G
Formoterol and Fluticasone (R03AK11) 3 products
WHO-DDD
DrugBank.ca
IP
CI
Flutiform 50/5
120
30.89
50.00
10 %
Druckgasinhalation: 2 Active Agents
Mundipharma Medical
Company, Hamilton,
Bermuda, Basel Branch
B / SL
FB
G
IP
CI
Flutiform 125/5
120
41.27
61.30
10 %
Druckgasinhalation: 2 Active Agents
Mundipharma Medical
Company, Hamilton,
Bermuda, Basel Branch
B / SL
FB
G
IP
CI
Flutiform 250/10
120
58.69
80.25
10 %
Druckgasinhalation: 2 Active Agents
Mundipharma Medical
Company, Hamilton,
Bermuda, Basel Branch
B / SL
FB
G
Indacaterol and Mometasone (R03AK14) 6 products
WHO-DDD
IP
CI
Atectura Breezhaler
150/80 μg
30
32.28
51.50
10 %
Inhalation Powder: 2 Active Agents
Novartis Pharma
Schweiz AG
B / SL
FB
G
IP
CI
Atectura Breezhaler
150/80 μg
90
96.74
121.65
10 %
Inhalation Powder: 2 Active Agents
Novartis Pharma
Schweiz AG
B / SL
FB
G
IP
CI
Atectura Breezhaler
150/160 μg
30
32.28
51.50
10 %
Inhalation Powder: 2 Active Agents
Novartis Pharma
Schweiz AG
B / SL
FB
G
IP
CI
Atectura Breezhaler
150/160 μg
90
96.74
121.65
10 %
Inhalation Powder: 2 Active Agents
Novartis Pharma
Schweiz AG
B / SL
FB
G
IP
CI
Atectura Breezhaler
150/320 μg
30
32.28
51.50
10 %
Inhalation Powder: 2 Active Agents
Novartis Pharma
Schweiz AG
B / SL
FB
G
IP
CI
Atectura Breezhaler
150/320 μg
90
96.74
121.65
10 %
Inhalation Powder: 2 Active Agents
Novartis Pharma
Schweiz AG
B / SL
FB
G
show caption
Red = Original
CM
= Co-Marketing
EFP = Ex-Factory-Price, exkl. VAT CHF
Green = Generic Drug
V/S
= vaccine/blood product
CP = Consumer Price, inkl. VAT CHF
Black = not classified
A
= Anesthetic
PR = Price request
Gray background = Pending Permission Extension
SIP
= Short Information for Professionals
SB = Selbstbehalt
H
= Homeopathics
IP
= Information for Professionals
DC = Daily Cost
A
= Anthroposophics
CI
= Consumer Information
SL = Official reimbursement list of Switzerland.
Ph
= Phytotherapeutics
L
= Limitations
SO = Original according to SL
Cas Reg.Nr. = CAS Registry
G
= Google Search by Product Name
SG = Generic according to SL
P
= Import parallel
FB
= Drugs Feedback
LPPA = Liste des produits pharmaceutiques pour application spéciale
Legal Disclaimer
ATC-Browser
|
Drugs A-Z
|
Recent Registrations
2025
©ywesee GmbH
Settings
|
Help
|
Login
|
Contact
|
Home